Abstract Extracellular Vesicles (EVs), particularly exosomes, recently exploded into
nanomedicine as an emerging drug delivery approach due to their superior biocompatibility …

Pancreatic cancer (PC) is the most lethal malignancy worldwide due to its delayed diagnosis
and limited treatment options. Despite great progress in clinical trials of immunotherapies for …

In designing a new drug, considering the preferred route of administration, various
requirements must be fulfilled. Active molecules pharmacokinetics should be reliable with a …

Bio-mimicking principles have recently been proposed for the surface functionalization of
nanoparticles (NPs). Such a strategy is based on camouflaging the NP surface with …

Osteosarcoma (OS) is a primary bone cancer that is highly prevalent among adolescents
and adults below the age of 20 years. The prognostic outcome of metastatic OS or relapse is …

Glioblastoma (GBM) has been regarded as one of the most deadly and challenging cancers
to treat with extremely poor prognosis. The limited efficacy of current chemotherapies might …

Osteosarcoma is a primary malignant tumor of the skeleton with the morbidity of 2.5 in 1
million. The regularly on-set is in the epiphysis of the extremities with a high possibility of …

Extracellular vesicles (EVs)-based cell-free strategy has shown therapeutic potential in
tissue regeneration. Due to their important roles in intercellular communications and their …

Cellular nanovesicles which are referred to as cell-derived, nanosized lipid bilayer
structures, have emerged as a promising platform for regulating immune responses. Owing …

Exosomes are membrane-bound nanoscale extracellular vesicles, which produced by
almost all organisms. Due to the excellent biocompatibility, long circulation time as well as …